AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 80 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -89.5% | 12,096 | -78.4% | 0.00% | -100.0% |
| Q4 2021 | $266,000 | +224.4% | 55,945 | +377.3% | 0.00% | +200.0% |
| Q2 2021 | $82,000 | -41.8% | 11,722 | -34.3% | 0.00% | -50.0% |
| Q1 2021 | $141,000 | +95.8% | 17,835 | +93.7% | 0.00% | +100.0% |
| Q4 2020 | $72,000 | +14.3% | 9,208 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $63,000 | -35.7% | 8,890 | -16.5% | 0.00% | -50.0% |
| Q2 2020 | $98,000 | -25.2% | 10,647 | -13.8% | 0.00% | -71.4% |
| Q2 2018 | $131,000 | – | 12,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |